Dengue vaccine: Takeda’s QDENGA® approved in Brazil

NewsDesk @bactiman63 Biopharmaceutical company, Takeda, announced recently the company's dengue vaccine, QDENGA(R) (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003), was approved in Brazil by the National Health Surveillance Agency (ANVISA) for the prevention of dengue caused by any of the four virus serotypes that can be found in individuals from 4 to 60 years of age. The use [...]

The post Dengue vaccine: Takeda's QDENGA(R) approved in Brazil appeared first on Outbreak News Today.